CeriBell (CBLL) Competitors $17.55 -0.63 (-3.47%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$17.55 0.00 (-0.03%) As of 05/21/2025 06:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock CBLL vs. LIVN, ENOV, NVCR, WRBY, SSII, CNMD, LMAT, TNDM, CDRE, and EYEShould you be buying CeriBell stock or one of its competitors? The main competitors of CeriBell include LivaNova (LIVN), Enovis (ENOV), NovoCure (NVCR), Warby Parker (WRBY), SS Innovations International (SSII), CONMED (CNMD), LeMaitre Vascular (LMAT), Tandem Diabetes Care (TNDM), Cadre (CDRE), and National Vision (EYE). These companies are all part of the "medical equipment" industry. CeriBell vs. LivaNova Enovis NovoCure Warby Parker SS Innovations International CONMED LeMaitre Vascular Tandem Diabetes Care Cadre National Vision LivaNova (NASDAQ:LIVN) and CeriBell (NASDAQ:CBLL) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, valuation, risk, institutional ownership, profitability, community ranking, media sentiment and dividends. Do insiders and institutionals hold more shares of LIVN or CBLL? 97.6% of LivaNova shares are held by institutional investors. 0.3% of LivaNova shares are held by company insiders. Comparatively, 20.1% of CeriBell shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Does the MarketBeat Community believe in LIVN or CBLL? LivaNova received 399 more outperform votes than CeriBell when rated by MarketBeat users. However, 100.00% of users gave CeriBell an outperform vote while only 69.80% of users gave LivaNova an outperform vote. CompanyUnderperformOutperformLivaNovaOutperform Votes40969.80% Underperform Votes17730.20% CeriBellOutperform Votes10100.00% Underperform VotesNo Votes Is LIVN or CBLL more profitable? LivaNova has a net margin of 1.91% compared to CeriBell's net margin of 0.00%. LivaNova's return on equity of 13.81% beat CeriBell's return on equity.Company Net Margins Return on Equity Return on Assets LivaNova1.91% 13.81% 7.07% CeriBell N/A N/A N/A Does the media prefer LIVN or CBLL? In the previous week, LivaNova had 9 more articles in the media than CeriBell. MarketBeat recorded 18 mentions for LivaNova and 9 mentions for CeriBell. CeriBell's average media sentiment score of 1.36 beat LivaNova's score of 1.33 indicating that CeriBell is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LivaNova 12 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CeriBell 8 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts recommend LIVN or CBLL? LivaNova presently has a consensus price target of $59.29, suggesting a potential upside of 35.79%. CeriBell has a consensus price target of $32.50, suggesting a potential upside of 85.19%. Given CeriBell's higher possible upside, analysts clearly believe CeriBell is more favorable than LivaNova.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score LivaNova 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 3.00CeriBell 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has stronger earnings & valuation, LIVN or CBLL? LivaNova has higher revenue and earnings than CeriBell. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLivaNova$1.28B1.87$17.55M-$4.09-10.67CeriBell$71.54M8.87N/AN/AN/A SummaryLivaNova beats CeriBell on 8 of the 14 factors compared between the two stocks. Get CeriBell News Delivered to You Automatically Sign up to receive the latest news and ratings for CBLL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CBLL vs. The Competition Export to ExcelMetricCeriBellElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$634.31M$3.26B$5.37B$8.39BDividend YieldN/A1.73%5.22%4.10%P/E RatioN/A16.6026.8419.71Price / Sales8.8785.43392.34117.39Price / CashN/A44.0938.2534.62Price / BookN/A3.736.794.50Net IncomeN/A$94.03M$3.23B$248.18M7 Day Performance-0.23%0.75%1.53%0.20%1 Month Performance18.82%20.87%10.05%12.37%1 Year PerformanceN/A-12.91%16.71%7.04% CeriBell Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CBLLCeriBell2.7337 of 5 stars$17.55-3.5%$32.50+85.2%N/A$634.31M$71.54M0.00N/APositive NewsInsider TradeLIVNLivaNova3.8004 of 5 stars$45.23+2.7%$59.17+30.8%-27.9%$2.47B$1.28B107.692,900Positive NewsAnalyst UpgradeHigh Trading VolumeENOVEnovis3.1864 of 5 stars$36.67+11.0%$55.00+50.0%-35.7%$2.09B$2.15B-16.746,800Gap UpHigh Trading VolumeNVCRNovoCure3.6341 of 5 stars$18.57+6.8%$32.83+76.8%-22.0%$2.07B$621.71M-13.261,320Positive NewsWRBYWarby Parker3.1265 of 5 stars$18.88+19.9%$22.21+17.6%+18.8%$1.97B$795.09M-69.943,030Trending NewsAnalyst ForecastHigh Trading VolumeSSIISS Innovations InternationalN/A$10.15+0.6%N/AN/A$1.96B$20.65M0.004High Trading VolumeCNMDCONMED4.1136 of 5 stars$60.75+6.4%$62.20+2.4%-23.3%$1.88B$1.32B14.334,100Positive NewsDividend AnnouncementLMATLeMaitre Vascular2.5947 of 5 stars$82.46+2.7%$98.14+19.0%+3.5%$1.86B$226.26M45.06490Insider TradeTNDMTandem Diabetes Care4.5167 of 5 stars$23.45+2.0%$39.81+69.8%-56.1%$1.56B$982.95M-12.152,600Positive NewsGap UpCDRECadre3.4742 of 5 stars$35.75+1.0%$37.00+3.5%+5.6%$1.45B$559.81M43.072,240Gap UpEYENational Vision2.7623 of 5 stars$18.76+9.3%$17.57-6.3%+18.0%$1.36B$1.85B-93.8014,000Positive NewsAnalyst ForecastGap UpHigh Trading Volume Related Companies and Tools Related Companies LivaNova Alternatives Enovis Alternatives NovoCure Alternatives Warby Parker Alternatives SS Innovations International Alternatives CONMED Alternatives LeMaitre Vascular Alternatives Tandem Diabetes Care Alternatives Cadre Alternatives National Vision Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CBLL) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersWarning: Prepare to Be Shocked by These PayoutsThere's a strategy out there paying up to 70% on tech stocks like Amazon, Tesla, and Microsoft—stocks that don...Investors Alley | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredTrump’s treachery I think Trump’s Treasury Secretary is destroying the stock market on purpose. And no one on Wall Street see...Porter & Company | Sponsored🚨 Nvidia Just Inked a $7B AI Deal—This Could Change EverythingOn Wednesday, Nvidia stock surged—again. Why? Because Saudi Arabia just announced a multi-billion-dollar AI...Timothy Sykes | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CeriBell Please log in to your account or sign up in order to add this asset to your watchlist. Share CeriBell With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CBLL Stock Free CBLL Stock Alerts